The results of the BEST-CLI trial were simultaneously published in the New England Journal of Medicine and presented at the American Heart Association Scientific Sessions.
Potential clinical applications include oncology and autoimmune diseases.
Recognition of obesity as a disease and earlier diagnosis of diabetes and other consequences of obesity will support early and more effective treatment and prevention.
Literature review finds that evidence-based interventions to address and eliminate racism and other systems of oppression in health care are needed.
Therapeutic strategies that specifically target this process might prove useful in alleviating severity of disease.
The goal is to expedite treatment, minimize unneeded invasive tests.
The assistant professor of pharmacology & experimental therapeutics focuses on human genetics and AD risk.
Investigators, institutions, journals and industry likely contribute to misinformation according to Howard Bauchner, MD.
These findings appear online in the journal Antimicrobial Agents and Chemotherapy.
Only a handful of scientists in the world have the capability to perform such research.